In its fourth quarter of 2025, Iradimed earned $22.7 million in revenue, a 17% improvement over the same period of 2024. Net ...

A team from the Institute of Neurosciences of the University of Barcelona (UBneuro) has discovered that early and sustained ...

We urgently need research to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi ...

IRADIMED CORPORATION (the 'Company” or 'Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and ...

People with a heightened risk of pancreatic cancer should be especially alert to the warning signals. This applies, for ...

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic ...

GAITHERSBURG, Md. - The U.S. Department of Commerce's National Institute of Standards and (NIST) is allocating funding totaling $3.19 ...

A supplement made from broccoli, green tea, and turmeric has slowed the rise of a prostate cancer blood marker in men monitored for early disease. That slowdown reframes how long some patients may ...

A team from the Institute of Neurosciences of the University of Barcelona (UBneuro) has discovered that early and sustained cognitive stimulation can ...

MASLD/MASH represents a growing clinical and economic burden, with MASH conferring heightened risks of advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related mortality. Noninvasive ...

Rhabdomyosarcoma, Peritonsillar Abscess, Round Blue Cell Tumour, Pediatric Malignancy Bansal, E. , Singhal, P. , Jhajhadia, B ...

A new study published in PNAS Nexus has found that specific patterns of brain activity can predict the success of persuasive messages across a wide variety of contexts. By analyzing neuroimaging data ...